This panel will discuss patent prosecution strategies for your bio/pharma innovations, including the following:

  • An update on best practices for drafting and prosecuting patent applications in light of generics, biosimilars, and post-grant challenges
  • The increased prevalence of inherent obviousness rejections at the USPTO
  • Effective project management and communication between outside and in-house counsel

Panel Moderator: Eric K. Steffe, Director

Panelist: Paul A. Calvo, Ph.D., Director

Panelist: Marsha Rose Gillentine, Ph.D., Director

Panelist: Andy Brookes, Section Head, IP Strategy, AbbVie

Panelist: Danielle Pasqualone, Ph.D., J.D., Executive Director, Intellectual Property, Five Prime Therapeutics, Inc